{"gene":"SP3","run_date":"2026-04-28T20:42:08","timeline":{"discoveries":[{"year":1994,"finding":"Sp3 represses Sp1-mediated transcriptional activation by competing with Sp1 for shared GC-box binding sites; a DNA-binding domain deletion mutant of Sp3 fails to inhibit Sp1, confirming competition-based mechanism. Sp3 cannot activate transcription in Drosophila SL2 cells lacking endogenous Sp factors, and chimeric domain-swap experiments show that Sp3 glutamine-rich and D domains cannot functionally replace Sp1 counterparts.","method":"Co-transfection in mammalian cells and Drosophila SL2 cells, deletion/chimeric mutant analysis, antibody generation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods (loss-of-function mutants, chimeric proteins, heterologous cell system), foundational study replicated across labs","pmids":["8070411"],"is_preprint":false},{"year":1997,"finding":"The Sp3 gene encodes multiple protein isoforms via internal translational initiation within the trans-activation domain; internally initiated Sp3 proteins (80 kDa) bind GC boxes but lack transcriptional activation capacity and instead function as potent repressors of Sp1/Sp3-mediated transcription.","method":"In vitro translation, transfection of reporter constructs, immunoblotting, mutational mapping of internal start sites","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (in vitro translation, functional reporter assays, mutational analysis) in single study","pmids":["9224612"],"is_preprint":false},{"year":2002,"finding":"Sp3 is sumoylated at a single lysine residue (K551) in vivo and in vitro; SUMO modification represses Sp3 transcriptional activity and relocalizes it to the nuclear periphery and nuclear dots. The SUMO-1 protease SuPr-1 or mutation of acceptor lysines converts Sp3 to a strong activator with diffuse nuclear localization. Covalent SUMO-1 fusion to Sp3 is sufficient to recapitulate repression and relocalization.","method":"SUMO acceptor lysine mutagenesis, SUMO-1 protease expression, SUMO-1 gene fusion, indirect immunofluorescence, transcription reporter assays","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1 — reconstitution (gene fusion), mutagenesis, localization imaging, and functional assays in one study","pmids":["12419227"],"is_preprint":false},{"year":2002,"finding":"PIAS1 acts as an E3 SUMO ligase for Sp3, stimulating SUMO conjugation at lysine within the IKXE motif located between the second glutamine-rich activation domain and the DNA-binding domain. SUMO-modified Sp3 binds DNA with similar specificity/affinity as unmodified Sp3, but DNA-bound Sp3 does not serve as a substrate for SUMO modification.","method":"In vivo and in vitro SUMO conjugation assays, mutational analysis of IKXE motif, co-immunoprecipitation of PIAS1 with Sp3 and Ubc9, transcriptional reporter assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro and in vivo assays with mutagenesis, identification of E3 ligase, replicated concept from PMID 12419227","pmids":["12356736"],"is_preprint":false},{"year":2001,"finding":"Sp3 transcriptional activity is regulated by acetylation; a single lysine residue is responsible for low in vivo activity of Sp3. Sp3 is highly acetylated in vivo, whereas a lysine mutant is not. In an in vitro transcription assay with Sp1/Sp3-depleted HeLa nuclear extract, recombinant Sp3 acts as a strong activator similar to Sp1, indicating that in vivo repression is post-translational.","method":"In vitro transcription assay with depleted nuclear extract, site-directed mutagenesis, in vivo acetylation assay, stable insect cell expression of recombinant proteins","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution combined with mutagenesis and in vivo acetylation measurement","pmids":["11812829"],"is_preprint":false},{"year":2000,"finding":"Genetic knockout of mouse Sp3 results in growth retardation, perinatal death due to respiratory failure, and pronounced defect in late tooth formation with impaired ameloblast-specific gene expression; Sp3-null phenotype is distinct from Sp1 knockout, demonstrating non-redundant in vivo functions.","method":"Homologous recombination gene knockout in mice, histology, surfactant protein expression analysis, comparison with Sp1 knockout phenotype","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined multi-organ phenotypic readouts, foundational in vivo study","pmids":["10675334"],"is_preprint":false},{"year":2008,"finding":"SUMO-modified Sp3 bound to DNA provokes local heterochromatic gene silencing by recruiting chromatin remodeller Mi-2, MBT-domain proteins, HP1, and histone methyltransferases SETDB1 and SUV4-20H, leading to H3K9 and H4K20 trimethylation.","method":"Chromatin immunoprecipitation (ChIP), reporter assays, sumoylation-competent/deficient Sp3 constructs","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — ChIP with multiple histone marks and co-repressor recruitment, mechanistically detailed","pmids":["18617891"],"is_preprint":false},{"year":2002,"finding":"Sp3 forms a separate complex from Sp1 in breast cancer cells and associates with CK2-phosphorylated HDAC2; protein kinase CK2 is associated with and phosphorylates HDAC2 recruited by Sp3, and alkaline phosphatase treatment reduces HDAC activity in Sp3 complexes.","method":"Co-immunoprecipitation, in vitro kinase assay, alkaline phosphatase treatment, chromatin crosslinking","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, in vitro kinase assay, and enzymatic validation","pmids":["12176973"],"is_preprint":false},{"year":2017,"finding":"Sp3 facilitates recruitment of HDAC2 to synaptic plasticity gene promoters in neurons; Sp3 knockdown phenocopies HDAC2 knockdown in reducing synaptic gene expression, and an HDAC2 fragment containing the Sp3-binding domain restores synaptic plasticity in a neurodegeneration mouse model.","method":"RNAi knockdown, integrative genomics/ChIP-seq, exogenous HDAC2 fragment rescue in mouse model","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — functional genomics, KD phenocopy, in vivo rescue experiment with defined molecular domain","pmids":["28793257"],"is_preprint":false},{"year":2004,"finding":"Sp3 is expressed as four isoforms arising from alternative translational start sites at positions 1, 37, 856, and 907; none of the isoforms is glycosylated (unlike Sp1); all four isoforms are SUMO-modified exclusively at lysine 551 in vivo and in vitro; the two long isoforms show promoter-context-dependent transcriptional activity regulated by SUMO modification, while the small isoforms are transcriptionally inactive.","method":"Immunoblot analysis in Sp3-deficient cell lines, in vitro SUMO conjugation, mutagenesis, translational initiation mapping, transcriptional reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — Sp3-null cell validation, in vitro SUMO assay, mutagenesis, multiple orthogonal methods","pmids":["15247228"],"is_preprint":false},{"year":2003,"finding":"Sp3 binds promoters containing multiple adjacent Sp-binding sites as a more stable multimeric complex compared to monomeric binding at single sites, and this promoter-dependent binding stability enables Sp3 to efficiently compete with Sp1 at multi-site promoters, blocking Sp1 synergistic transactivation without Sp3 itself synergistically activating transcription.","method":"EMSA mobility shift analysis, promoter-specific transcription assays, complex stability measurements","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — mechanistic EMSA and functional assays but single lab, single study","pmids":["12954773"],"is_preprint":false},{"year":2001,"finding":"Sp3 is required for proper skeletal ossification; both endochondral and intramembranous ossification are impaired in Sp3-/- embryos, osteocalcin expression is reduced, and Sp3-/- ES cells show reduced osteogenic differentiation capacity in vitro despite normal Cbfa1 expression.","method":"Sp3 knockout mice analysis, in vitro ES cell osteogenic differentiation, gene expression analysis","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and molecular phenotype, in vitro differentiation assay corroboration","pmids":["11472836"],"is_preprint":false},{"year":2003,"finding":"Sp3 is required for normal hematopoiesis; Sp3-/- mice show T-cell developmental arrest, reduced B-cell numbers, and a cell-autonomous defect in erythroid and myeloid engraftment in transplantation assays, with a specific delay in definitive erythropoiesis.","method":"Sp3 knockout mice analysis, in vitro differentiation, in vivo bone marrow transplantation assay","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — clean KO with cell-autonomous proof via transplantation, defined lineage-specific phenotypes","pmids":["12676787"],"is_preprint":false},{"year":2007,"finding":"Sp3-null mice on C57BL/6 background develop severe cardiac malformations including defective heart looping at E10.5 and structural defects by E14.5; ChIP shows Sp3 directly bound to the Carp promoter in vivo, and Carp expression is prematurely downregulated in Sp3-null hearts; Wt1 expression in epicardium-derived cells is also diminished.","method":"Sp3 knockout mice cardiac analysis, ChIP assay for Carp promoter occupancy, microarray analysis, marker gene expression panel","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — KO with defined phenotype, ChIP validation of direct target binding, microarray pathway analysis","pmids":["17923686"],"is_preprint":false},{"year":2014,"finding":"Combined conditional knockout of Sp1 and Sp3 in megakaryocytes causes severe macrothrombocytopenia with a cell-autonomous defect in proplatelet formation and a less compact demarcation membrane system; Sp1/Sp3 depletion downregulates cytoskeleton-related proteins including Mylk, and Mylk inhibition phenocopies the proplatelet defect.","method":"Pf4-Cre conditional double-knockout mice, flow cytometry, electron microscopy, megakaryocyte transcriptomics, platelet proteomics, Mylk inhibitor treatment","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific conditional KO with multi-omic validation and pharmacological phenocopy","pmids":["25538045"],"is_preprint":false},{"year":2001,"finding":"c-Myc interacts with Sp1/Sp3 via the central region of c-Myc binding to the zinc finger domain of Sp1/Sp3, and this interaction likely sequesters Sp1/Sp3 to repress p21 promoter activity; the p21 promoter region repressed by Myc contains only Sp1-binding sites and no canonical Myc E-box.","method":"Co-immunoprecipitation, GST pulldown, transcriptional reporter assays, 4-OHT-inducible Myc-ER fusion","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — reciprocal Co-IP and GST pulldown demonstrate physical interaction; functional link established by reporter assay","pmids":["11274368"],"is_preprint":false},{"year":2007,"finding":"Glutamate receptor activation triggers calpain-mediated cleavage of Sp3 and Sp4 in neurons; purified calpain I cleaves Sp3 into products that retain GC/T-binding activity; this is blocked by calpain inhibitors and observed after cerebral ischemia/reperfusion in vivo.","method":"In vitro calpain cleavage assay with purified proteins, calpain inhibitor treatment, in vivo ischemia model, immunofluorescence, western blot","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 — purified protein in vitro cleavage assay corroborated by inhibitor studies and in vivo model","pmids":["17316402"],"is_preprint":false},{"year":2005,"finding":"Sp3 interacts with GABPα through its zinc finger DNA-binding domain, and both Sp1 and Sp3 synergistically activate the utrophin promoter together with GABP; physical interaction between Sp factors and GABPα was demonstrated by in vitro binding assays and domain mapping.","method":"In vitro protein-protein interaction assays, domain deletion analysis, co-transfection in Drosophila SL2 cells, transcriptional reporter assays","journal":"Journal of molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro pulldown with domain mapping; functional synergy demonstrated in heterologous cells","pmids":["11237613"],"is_preprint":false},{"year":2002,"finding":"p300 physically interacts with Sp3 in vivo and in vitro, and cotransfection of p300 elevates Sp3-mediated activation of the p21 promoter; a p300 dominant-negative mutant blocks Sp1- or Sp3-mediated activation, placing p300 as a co-activator of Sp3.","method":"Co-immunoprecipitation, in vitro binding assay, dominant-negative p300 co-transfection, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and in vitro binding plus dominant-negative functional validation; single lab","pmids":["12071960"],"is_preprint":false},{"year":2005,"finding":"Sp1 and Sp3 are organized into distinct non-overlapping nuclear domains in human cells; Sp3 partitions preferentially with the tightly bound nuclear protein fraction and nuclear matrix, while Sp1 and Sp3 associate with different nuclear matrix attachment sites; ChIP/re-ChIP shows Sp1 and Sp3 do not co-occupy the same trefoil factor 1 promoter simultaneously.","method":"Indirect immunofluorescence with deconvolution microscopy, nuclear fractionation, nuclear matrix preparation, ChIP and re-ChIP assays","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal localization methods and re-ChIP demonstrating mutually exclusive promoter occupancy","pmids":["15987735"],"is_preprint":false},{"year":2005,"finding":"Sumoylation of internally initiated Sp3 isoforms (M1 and M2) is required for their repressive activity; mutation of K551 converts M1 from a repressor into a potent transcriptional activator; Ubc9 (SUMO-1 conjugating enzyme) was identified as an M2-binding protein by yeast two-hybrid.","method":"Yeast two-hybrid screen, in vivo SUMO conjugation assay, K551R mutagenesis, transcriptional reporter assays","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — mutagenesis and SUMO assays; yeast two-hybrid interaction supported by functional data","pmids":["15494207"],"is_preprint":false},{"year":2006,"finding":"Sp3 acetylation (catalyzed by p300 acetyltransferase) in response to sodium butyrate represses hIGFBP-3 expression; EMSA of nuclei from butyrate-treated cells reveals an extra, slower Sp3-DNA complex recognized by both anti-Sp3 and anti-acetyl-lysine antibodies; E1A (p300 inhibitor) reverses butyrate-induced repression.","method":"EMSA with antibody detection, E1A co-transfection, reporter assays, inhibitor treatment","journal":"Journal of pediatric gastroenterology and nutrition","confidence":"Medium","confidence_rationale":"Tier 2 — dual-antibody EMSA and functional rescue; single lab, limited direct acetyltransferase assay","pmids":["16456404"],"is_preprint":false},{"year":2013,"finding":"NF-κB RELA subunit interacts with SP3 and this RELA-SP3 interaction is enhanced by NF-κB activation (LPS or constitutively active IKKβ); the RELA-SP3 complex suppresses SP1-mediated FGF-10 transcription; the N-terminal region of SP3 is required for its inhibitory function; dominant-negative IκB prevents SP3-mediated FGF-10 inhibition.","method":"ChIP of Fgf-10 promoter in LPS-treated cells, co-IP of RELA and SP3, constitutively active/dominant-negative IKK constructs, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and Co-IP with mechanistic functional validation; single lab","pmids":["23558680"],"is_preprint":false},{"year":2010,"finding":"Sp3 binds the Notch1 gene promoter and represses its transcription in keratinocytes; combined Klf4 and Sp3 knockdown is required to increase Notch1 transcription, indicating overlapping repressor functions through promoter binding.","method":"Combined siRNA knockdown, reporter assays with GC-rich promoter, binding analysis","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 3 — functional knockdown data, promoter binding shown; no direct ChIP or in vitro reconstitution","pmids":["20442780"],"is_preprint":false},{"year":2006,"finding":"Sp3 mRNA is predominant in neurons (compared to Sp1), and Sp3 protein is present at lower levels in glia; calpain cleaves Sp3 into species that retain DNA binding activity, with cleavage also occurring after ischemia/reperfusion in vivo.","method":"RT-PCR, western blot, immunofluorescence, DNA-binding supershift assay, purified calpain in vitro cleavage","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro cleavage with purified enzyme plus in vivo validation; same paper as PMID 17316402","pmids":["17316402"],"is_preprint":false},{"year":2006,"finding":"In cortical neurons, Sp3 (along with Sp3/Sp4) is the predominant Sp-family DNA-binding factor rather than Sp1; full-length Sp3 overexpression prevents neuronal death in response to oxidative stress and DNA damage in a DNA-binding-domain-dependent manner.","method":"Overexpression of full-length Sp3 vs. zinc-finger-only constructs, neuronal survival assay under oxidative stress, western blot/nuclear fractionation","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — domain-specific rescue and defined cell death assay; single study","pmids":["12736330"],"is_preprint":false},{"year":2015,"finding":"ChIP-seq in mouse embryonic fibroblasts shows Sp1 and Sp3 occupy essentially the same promoters and localize to GC boxes genome-wide; re-expression of Sp3 in knockout MEFs confirms that the zinc finger domain dictates Sp3 genomic binding site selection, distinguishing it from Sp2.","method":"ChIP-seq, re-expression in knockout MEFs, zinc-finger deletion mutants","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1 — genome-wide ChIP-seq with mutant rescue in KO cells","pmids":["25793500"],"is_preprint":false},{"year":2010,"finding":"Sp3, together with ATF-2, forms a complex at the ITGB8 (integrin β8) core promoter in a p38 MAPK-dependent manner; Sp3 is required for ITGB8 transcription and protein expression, and SP3 reduction blocks αvβ8-mediated TGF-β activation.","method":"ChIP, co-IP showing Sp1/Sp3/AP-1 complex, siRNA knockdown, p38 inhibitor, reporter assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and co-IP with functional pathway validation; single lab","pmids":["20519498"],"is_preprint":false},{"year":2019,"finding":"Sp3 and Sp1 binding sites largely overlap in hematopoietic progenitors by ChIP-seq; Sp3 cooperates with a DNA-binding mutant of Sp1 (Sp1ΔDBD) to enable hematopoiesis, but cannot rescue hematopoiesis in complete absence of Sp1; Sp1 DNA binding is required for proper timing and coordination of differentiation trajectories as revealed by single-cell gene expression analysis.","method":"ChIP-seq, genetic complementation in Sp1ΔDBD ES cells, single-cell gene expression analysis, in vitro hematopoietic differentiation","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 2 — genome-wide ChIP-seq, genetic complementation, single-cell analysis; multiple orthogonal approaches","pmids":["31164147"],"is_preprint":false}],"current_model":"SP3 is a ubiquitous GC-box-binding zinc-finger transcription factor that can both activate and repress transcription depending on promoter context, post-translational modification state, and isoform: it competes with Sp1 for shared binding sites, is sumoylated at K551 by the E3 ligase PIAS1 (leading to transcriptional silencing via heterochromatin formation involving SETDB1, SUV4-20H, and HP1 recruitment), is regulated by acetylation and calpain-mediated cleavage, forms distinct nuclear complexes with HDAC2 (recruited to synaptic genes) and interacts physically with p300, RELA/NF-κB, and GABP; Sp3 is essential in vivo for tooth development, ossification, hematopoiesis, cardiac morphogenesis, and platelet formation, as demonstrated by knockout mouse studies."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing that SP3 is not simply redundant with SP1 but acts as a GC-box competitor that represses SP1-mediated activation, answering the fundamental question of why two factors with identical DNA-binding specificity coexist.","evidence":"Co-transfection in mammalian and Drosophila SL2 cells with deletion and chimeric mutants of SP3","pmids":["8070411"],"confidence":"High","gaps":["Mechanism of repression beyond site competition was unknown","Whether SP3 could activate transcription in any context remained open","In vivo relevance of competition not tested"]},{"year":1997,"claim":"Discovery that the SP3 gene produces multiple isoforms via internal translational initiation resolved why SP3 behaves as a repressor in most contexts — the shorter isoforms lack activation domains and act as dominant repressors.","evidence":"In vitro translation, mutagenesis of internal start sites, reporter assays","pmids":["9224612"],"confidence":"High","gaps":["Post-translational modifications of individual isoforms not characterized","Relative abundance of isoforms in different tissues unknown"]},{"year":2000,"claim":"Knockout of SP3 in mice revealed essential, non-redundant in vivo roles in tooth development and surfactant production, establishing that SP3 loss is not compensated by SP1.","evidence":"Homologous recombination gene knockout in mice with histological and gene expression analysis","pmids":["10675334"],"confidence":"High","gaps":["Molecular targets in ameloblasts not identified","Cause of respiratory failure not fully dissected","Conditional tissue-specific requirements not tested"]},{"year":2001,"claim":"Two parallel discoveries — that SP3 is regulated by acetylation at a critical lysine and that SP3 is required for skeletal ossification — expanded the picture of SP3 as a post-translationally regulated factor with broad developmental functions.","evidence":"In vitro transcription with SP1/SP3-depleted nuclear extract and acetylation mutagenesis (PMID:11812829); SP3 knockout mouse skeletal analysis and ES cell osteogenic differentiation (PMID:11472836)","pmids":["11812829","11472836"],"confidence":"High","gaps":["Identity of the acetyltransferase responsible in vivo not determined at this stage","Relationship between acetylation and sumoylation at the same or nearby lysines unclear"]},{"year":2002,"claim":"The discovery that SUMO modification at K551, catalyzed by E3 ligase PIAS1, switches SP3 from activator to repressor and relocalizes it to nuclear bodies provided the central post-translational mechanism controlling SP3 activity.","evidence":"SUMO acceptor lysine mutagenesis, SUMO-1 gene fusions, immunofluorescence, in vitro/in vivo SUMO conjugation assays with PIAS1","pmids":["12419227","12356736"],"confidence":"High","gaps":["How SUMO-SP3 recruits silencing machinery not yet established","Regulation of PIAS1-mediated sumoylation in physiological contexts unknown","Whether desumoylation is signal-regulated not addressed"]},{"year":2002,"claim":"Identification of SP3 in a distinct nuclear complex with CK2-phosphorylated HDAC2, separate from SP1 complexes, established that SP3 mediates transcriptional repression through histone deacetylase recruitment.","evidence":"Reciprocal co-immunoprecipitation, in vitro kinase assay, alkaline phosphatase treatment in breast cancer cells","pmids":["12176973"],"confidence":"High","gaps":["Genomic targets of the SP3-HDAC2 complex not mapped","Whether SUMO modification of SP3 is required for HDAC2 interaction not tested"]},{"year":2003,"claim":"Demonstration of cell-autonomous hematopoietic defects in SP3-null mice — including arrested T-cell development, reduced B cells, and impaired erythropoiesis — broadened SP3's essential developmental roles to the blood system.","evidence":"SP3 knockout mice with bone marrow transplantation proving cell-autonomous defects, in vitro differentiation assays","pmids":["12676787"],"confidence":"High","gaps":["Direct transcriptional targets in hematopoietic progenitors not identified","Relative contribution of SP3 isoforms to hematopoiesis unknown"]},{"year":2005,"claim":"High-resolution imaging and re-ChIP studies revealed that SP1 and SP3 occupy distinct non-overlapping nuclear domains and do not co-occupy the same promoter molecule simultaneously, reframing the competition model as one of mutually exclusive occupancy.","evidence":"Deconvolution microscopy, nuclear matrix fractionation, ChIP/re-ChIP at trefoil factor 1 promoter","pmids":["15987735"],"confidence":"High","gaps":["Whether mutual exclusivity applies genome-wide or only at select loci not determined","Dynamic exchange rates between SP1 and SP3 at promoters not measured"]},{"year":2007,"claim":"SP3 was shown to be essential for cardiac morphogenesis, with direct ChIP evidence of SP3 binding to the Carp promoter in vivo, linking SP3 loss to defective heart looping and structural malformations.","evidence":"SP3 knockout mice on C57BL/6 background, ChIP of Carp promoter, microarray analysis of E10.5 hearts","pmids":["17923686"],"confidence":"High","gaps":["Full set of direct cardiac target genes not delineated","Whether cardiac defect is SP3-isoform specific not tested"]},{"year":2008,"claim":"The mechanistic link between SUMO-SP3 and heterochromatin was completed by showing that DNA-bound sumoylated SP3 recruits Mi-2, MBT-domain proteins, HP1, SETDB1, and SUV4-20H to trigger H3K9me3 and H4K20me3, explaining how a single transcription factor nucleates stable gene silencing.","evidence":"ChIP for multiple histone marks and co-repressor proteins using sumoylation-competent and -deficient SP3 constructs","pmids":["18617891"],"confidence":"High","gaps":["Whether this heterochromatin mechanism operates at endogenous SP3 target genes genome-wide unknown","Structural basis for SUMO-dependent co-repressor recruitment not resolved"]},{"year":2015,"claim":"Genome-wide ChIP-seq confirmed that SP1 and SP3 occupy essentially identical GC-box promoter sites, and that the zinc-finger domain alone dictates SP3 binding-site selection, resolving the question of genomic target overlap at a global scale.","evidence":"ChIP-seq in wild-type and SP3 knockout MEFs with zinc-finger deletion mutant re-expression","pmids":["25793500"],"confidence":"High","gaps":["What determines differential functional outcomes (activation vs. repression) at shared sites not explained by binding alone","Contribution of non-DNA-binding cofactor interactions to target gene selectivity unclear"]},{"year":2017,"claim":"SP3 was shown to facilitate HDAC2 recruitment specifically to synaptic plasticity gene promoters in neurons, with SP3 knockdown phenocopying HDAC2 loss, establishing a neuronal gene-regulatory function for the SP3-HDAC2 axis.","evidence":"RNAi knockdown, ChIP-seq, and HDAC2 fragment rescue in a neurodegeneration mouse model","pmids":["28793257"],"confidence":"High","gaps":["Whether SP3 sumoylation is required for HDAC2 recruitment to synaptic genes not tested","Which SP3 isoforms operate in mature neurons not determined"]},{"year":2019,"claim":"Single-cell and ChIP-seq analyses in hematopoietic progenitors showed that SP3 cooperates with SP1 but cannot substitute for SP1's DNA-binding function, establishing a model of obligate SP1-SP3 partnership rather than simple redundancy in hematopoiesis.","evidence":"ChIP-seq in hematopoietic progenitors, genetic complementation with SP1 DNA-binding-domain mutant, single-cell gene expression profiling","pmids":["31164147"],"confidence":"High","gaps":["Biochemical nature of SP1-SP3 functional cooperation at shared sites not defined","Whether SP3-specific cofactors contribute to non-redundant hematopoietic functions unknown"]},{"year":null,"claim":"It remains unresolved how cells regulate the switch between activating and repressive SP3 states at specific genomic loci, including the signaling pathways that control the balance of SP3 sumoylation, acetylation, and isoform expression in different developmental and physiological contexts.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of SP3 or its SUMO-modified form exists","Genome-wide mapping of SUMO-SP3 versus unmodified SP3 occupancy has not been performed","The interplay between SP3 acetylation and sumoylation at the same critical lysine region is not resolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,10,26]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,1,2,6,8,26]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,19]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[19]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,6,8,26]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[6]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,11,12,13,14]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[12,28]}],"complexes":["SP3-HDAC2-CK2 complex","SUMO-SP3/SETDB1/HP1/Mi-2 silencing complex"],"partners":["SP1","HDAC2","PIAS1","UBE2I","EP300","RELA","GABPA","MYC"],"other_free_text":[]},"mechanistic_narrative":"SP3 is a ubiquitously expressed zinc-finger transcription factor that binds GC-box elements genome-wide, functioning as both an activator and a repressor of transcription depending on isoform, promoter context, and post-translational modification state. SP3 competes with SP1 for shared GC-box sites, and its shorter internally initiated isoforms lack activation capacity, serving as potent transcriptional repressors [PMID:8070411, PMID:9224612, PMID:25793500]. SUMO conjugation at K551, mediated by the E3 ligase PIAS1, converts SP3 into a silencer that recruits heterochromatin factors including SETDB1, SUV4-20H, HP1, and Mi-2, leading to H3K9 and H4K20 trimethylation, while acetylation by p300 and calpain-mediated cleavage provide additional regulatory inputs [PMID:12419227, PMID:12356736, PMID:18617891, PMID:17316402]. SP3 is essential in vivo for tooth development, ossification, hematopoiesis, cardiac morphogenesis, and proplatelet formation, demonstrating non-redundant functions distinct from SP1 [PMID:10675334, PMID:11472836, PMID:12676787, PMID:17923686, PMID:25538045]."},"prefetch_data":{"uniprot":{"accession":"Q02447","full_name":"Transcription factor Sp3","aliases":["SPR-2"],"length_aa":781,"mass_kda":81.9,"function":"Transcriptional factor that can act as an activator or repressor depending on isoform and/or post-translational modifications. Binds to GT and GC boxes promoter elements. Competes with SP1 for the GC-box promoters. Weak activator of transcription but can activate a number of genes involved in different processes such as cell-cycle regulation, hormone-induction and house-keeping","subcellular_location":"Nucleus; Nucleus, PML body","url":"https://www.uniprot.org/uniprotkb/Q02447/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SP3","classification":"Not Classified","n_dependent_lines":79,"n_total_lines":1208,"dependency_fraction":0.06539735099337748},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SP3","total_profiled":1310},"omim":[{"mim_id":"614353","title":"HAS2 ANTISENSE RNA 1; HAS2AS1","url":"https://www.omim.org/entry/614353"},{"mim_id":"614232","title":"11-@BETA-HYDROXYSTEROID DEHYDROGENASE, TYPE II; HSD11B2","url":"https://www.omim.org/entry/614232"},{"mim_id":"613218","title":"CYTOCHROME b5, TYPE A (MICROSOMAL); CYB5A","url":"https://www.omim.org/entry/613218"},{"mim_id":"609300","title":"CYTOCHROME P450, FAMILY 17, SUBFAMILY A, POLYPEPTIDE 1; CYP17A1","url":"https://www.omim.org/entry/609300"},{"mim_id":"608791","title":"NUCLEOREDOXIN-LIKE PROTEIN 1; NXNL1","url":"https://www.omim.org/entry/608791"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/SP3"},"hgnc":{"alias_symbol":["SPR-2"],"prev_symbol":[]},"alphafold":{"accession":"Q02447","domains":[{"cath_id":"3.30.160,3.30.160","chopping":"679-708","consensus_level":"medium","plddt":81.2093,"start":679,"end":708}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02447","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q02447-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q02447-F1-predicted_aligned_error_v6.png","plddt_mean":37.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SP3","jax_strain_url":"https://www.jax.org/strain/search?query=SP3"},"sequence":{"accession":"Q02447","fasta_url":"https://rest.uniprot.org/uniprotkb/Q02447.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q02447/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q02447"}},"corpus_meta":[{"pmid":"8070411","id":"PMC_8070411","title":"Sp1-mediated transcriptional activation is repressed by Sp3.","date":"1994","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8070411","citation_count":676,"is_preprint":false},{"pmid":"15284899","id":"PMC_15284899","title":"Gene regulation by Sp1 and Sp3.","date":"2004","source":"Biochemistry and cell biology = Biochimie et biologie cellulaire","url":"https://pubmed.ncbi.nlm.nih.gov/15284899","citation_count":353,"is_preprint":false},{"pmid":"11274368","id":"PMC_11274368","title":"Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11274368","citation_count":348,"is_preprint":false},{"pmid":"12419227","id":"PMC_12419227","title":"SUMO-1 modification represses Sp3 transcriptional activation and modulates its subnuclear localization.","date":"2002","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/12419227","citation_count":311,"is_preprint":false},{"pmid":"20810260","id":"PMC_20810260","title":"The role of Sp1 and Sp3 in normal and cancer cell biology.","date":"2010","source":"Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft","url":"https://pubmed.ncbi.nlm.nih.gov/20810260","citation_count":284,"is_preprint":false},{"pmid":"28948796","id":"PMC_28948796","title":"Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range.","date":"2017","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/28948796","citation_count":234,"is_preprint":false},{"pmid":"9224612","id":"PMC_9224612","title":"Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9224612","citation_count":230,"is_preprint":false},{"pmid":"32129943","id":"PMC_32129943","title":"Automated sample preparation with SP3 for low-input clinical proteomics.","date":"2020","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/32129943","citation_count":225,"is_preprint":false},{"pmid":"12356736","id":"PMC_12356736","title":"Transcription factor Sp3 is silenced through SUMO modification by PIAS1.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12356736","citation_count":225,"is_preprint":false},{"pmid":"29565595","id":"PMC_29565595","title":"Extending the Compatibility of the SP3 Paramagnetic Bead Processing Approach for Proteomics.","date":"2018","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/29565595","citation_count":212,"is_preprint":false},{"pmid":"12736330","id":"PMC_12736330","title":"Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12736330","citation_count":195,"is_preprint":false},{"pmid":"10675334","id":"PMC_10675334","title":"Transcription factor Sp3 is essential for post-natal survival and late tooth development.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10675334","citation_count":170,"is_preprint":false},{"pmid":"12509426","id":"PMC_12509426","title":"Oxidative stress regulates vascular endothelial growth factor-A gene transcription through Sp1- and Sp3-dependent activation of two proximal GC-rich promoter elements.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12509426","citation_count":165,"is_preprint":false},{"pmid":"10625687","id":"PMC_10625687","title":"p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10625687","citation_count":151,"is_preprint":false},{"pmid":"9748288","id":"PMC_9748288","title":"Hypoxia regulates beta-enolase and pyruvate kinase-M promoters by modulating Sp1/Sp3 binding to a conserved GC element.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9748288","citation_count":144,"is_preprint":false},{"pmid":"11812829","id":"PMC_11812829","title":"Transcription factor Sp3 is regulated by acetylation.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11812829","citation_count":129,"is_preprint":false},{"pmid":"8995437","id":"PMC_8995437","title":"Involvement of the Sp3 transcription factor in induction of p21Cip1/WAF1 in keratinocyte differentiation.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8995437","citation_count":129,"is_preprint":false},{"pmid":"10321829","id":"PMC_10321829","title":"Both Sp1 and Sp3 are responsible for p21waf1 promoter activity induced by histone deacetylase inhibitor in NIH3T3 cells.","date":"1999","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10321829","citation_count":129,"is_preprint":false},{"pmid":"11493684","id":"PMC_11493684","title":"Cross talk among calcineurin, Sp1/Sp3, and NFAT in control of p21(WAF1/CIP1) expression in keratinocyte differentiation.","date":"2001","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11493684","citation_count":128,"is_preprint":false},{"pmid":"12700237","id":"PMC_12700237","title":"Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12700237","citation_count":113,"is_preprint":false},{"pmid":"11472836","id":"PMC_11472836","title":"Impaired ossification in mice lacking the transcription factor Sp3.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11472836","citation_count":98,"is_preprint":false},{"pmid":"9580699","id":"PMC_9580699","title":"Sp1, but not Sp3, functions to mediate promoter activation by TGF-beta through canonical Sp1 binding sites.","date":"1998","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9580699","citation_count":95,"is_preprint":false},{"pmid":"15247228","id":"PMC_15247228","title":"Complexity of translationally controlled transcription factor Sp3 isoform expression.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15247228","citation_count":92,"is_preprint":false},{"pmid":"9278495","id":"PMC_9278495","title":"Sp3 is a transcriptional activator of the human alpha2(I) collagen gene.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9278495","citation_count":91,"is_preprint":false},{"pmid":"12071960","id":"PMC_12071960","title":"Regulation of transcription of the Dnmt1 gene by Sp1 and Sp3 zinc finger proteins.","date":"2002","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12071960","citation_count":89,"is_preprint":false},{"pmid":"24861163","id":"PMC_24861163","title":"CpG methylation regulates allelic expression of GDF5 by modulating binding of SP1 and SP3 repressor proteins to the osteoarthritis susceptibility SNP rs143383.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24861163","citation_count":85,"is_preprint":false},{"pmid":"9115370","id":"PMC_9115370","title":"Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1.","date":"1997","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/9115370","citation_count":83,"is_preprint":false},{"pmid":"12954773","id":"PMC_12954773","title":"Stability of the Sp3-DNA complex is promoter-specific: Sp3 efficiently competes with Sp1 for binding to promoters containing multiple Sp-sites.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/12954773","citation_count":83,"is_preprint":false},{"pmid":"26967243","id":"PMC_26967243","title":"Specificity protein (Sp) transcription factors Sp1, Sp3 and Sp4 are non-oncogene addiction genes in cancer cells.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26967243","citation_count":81,"is_preprint":false},{"pmid":"28793257","id":"PMC_28793257","title":"The Transcription Factor Sp3 Cooperates with HDAC2 to Regulate Synaptic Function and Plasticity in Neurons.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28793257","citation_count":81,"is_preprint":false},{"pmid":"11447232","id":"PMC_11447232","title":"Sp3 represses the Sp1-mediated transactivation of the human COL2A1 gene in primary and de-differentiated chondrocytes.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11447232","citation_count":80,"is_preprint":false},{"pmid":"17350596","id":"PMC_17350596","title":"Sp1 and Sp3 regulate basal transcription of the survivin gene.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17350596","citation_count":79,"is_preprint":false},{"pmid":"12176973","id":"PMC_12176973","title":"The transcriptional repressor Sp3 is associated with CK2-phosphorylated histone deacetylase 2.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12176973","citation_count":78,"is_preprint":false},{"pmid":"35848328","id":"PMC_35848328","title":"Solvent Precipitation SP3 (SP4) Enhances Recovery for Proteomics Sample Preparation without Magnetic Beads.","date":"2022","source":"Analytical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35848328","citation_count":76,"is_preprint":false},{"pmid":"18617891","id":"PMC_18617891","title":"SUMO-modified Sp3 represses transcription by provoking local heterochromatic gene silencing.","date":"2008","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/18617891","citation_count":73,"is_preprint":false},{"pmid":"9677424","id":"PMC_9677424","title":"Differential effects of heterogeneous nuclear ribonucleoprotein K on Sp1- and Sp3-mediated transcriptional activation of a neuronal nicotinic acetylcholine receptor promoter.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9677424","citation_count":70,"is_preprint":false},{"pmid":"9666093","id":"PMC_9666093","title":"Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9666093","citation_count":68,"is_preprint":false},{"pmid":"12378384","id":"PMC_12378384","title":"Identification of regulatory elements in the human adipose most abundant gene transcript-1 ( apM-1) promoter: role of SP1/SP3 and TNF-alpha as regulatory pathways.","date":"2002","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/12378384","citation_count":67,"is_preprint":false},{"pmid":"11237613","id":"PMC_11237613","title":"Sp1 and Sp3 physically interact and co-operate with GABP for the activation of the utrophin promoter.","date":"2001","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11237613","citation_count":64,"is_preprint":false},{"pmid":"15523672","id":"PMC_15523672","title":"Specificity of transcriptional regulation by the zinc finger transcription factors Sp1, Sp3, and Egr-1.","date":"2005","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15523672","citation_count":64,"is_preprint":false},{"pmid":"18725933","id":"PMC_18725933","title":"An Sp1/Sp3 binding polymorphism confers methylation protection.","date":"2008","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18725933","citation_count":58,"is_preprint":false},{"pmid":"15541732","id":"PMC_15541732","title":"Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15541732","citation_count":57,"is_preprint":false},{"pmid":"28844709","id":"PMC_28844709","title":"The miR-491-3p/Sp3/ABCB1 axis attenuates multidrug resistance of hepatocellular carcinoma.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28844709","citation_count":56,"is_preprint":false},{"pmid":"15987735","id":"PMC_15987735","title":"Differential intranuclear organization of transcription factors Sp1 and Sp3.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/15987735","citation_count":56,"is_preprint":false},{"pmid":"12554796","id":"PMC_12554796","title":"Transactivation of the progesterone receptor gene in granulosa cells: evidence that Sp1/Sp3 binding sites in the proximal promoter play a key role in luteinizing hormone inducibility.","date":"2002","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/12554796","citation_count":55,"is_preprint":false},{"pmid":"26352013","id":"PMC_26352013","title":"Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.","date":"2015","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26352013","citation_count":54,"is_preprint":false},{"pmid":"15816870","id":"PMC_15816870","title":"Sp1 and Sp3 activate transcription of the human dopamine transporter gene.","date":"2005","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15816870","citation_count":52,"is_preprint":false},{"pmid":"25538045","id":"PMC_25538045","title":"Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function.","date":"2014","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/25538045","citation_count":52,"is_preprint":false},{"pmid":"10556032","id":"PMC_10556032","title":"GLUT1 glucose transporter gene transcription is repressed by Sp3. Evidence for a regulatory role of Sp3 during myogenesis.","date":"1999","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10556032","citation_count":52,"is_preprint":false},{"pmid":"11796707","id":"PMC_11796707","title":"A novel role of Sp1 and Sp3 in the interferon-gamma -mediated suppression of macrophage lipoprotein lipase gene transcription.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11796707","citation_count":48,"is_preprint":false},{"pmid":"19289038","id":"PMC_19289038","title":"Protein structure prediction by pro-Sp3-TASSER.","date":"2009","source":"Biophysical journal","url":"https://pubmed.ncbi.nlm.nih.gov/19289038","citation_count":47,"is_preprint":false},{"pmid":"11495920","id":"PMC_11495920","title":"Novel transcriptional regulation of the human CYP3A7 gene by Sp1 and Sp3 through nuclear factor kappa B-like element.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11495920","citation_count":46,"is_preprint":false},{"pmid":"25793500","id":"PMC_25793500","title":"Zinc finger independent genome-wide binding of Sp2 potentiates recruitment of histone-fold protein Nf-y distinguishing it from Sp1 and Sp3.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25793500","citation_count":45,"is_preprint":false},{"pmid":"11804877","id":"PMC_11804877","title":"Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells.","date":"2002","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/11804877","citation_count":45,"is_preprint":false},{"pmid":"14645238","id":"PMC_14645238","title":"E2F and Sp1/Sp3 Synergize but are not sufficient to activate the MYCN gene in neuroblastomas.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14645238","citation_count":44,"is_preprint":false},{"pmid":"17316402","id":"PMC_17316402","title":"Glutamate receptor activation evokes calpain-mediated degradation of Sp3 and Sp4, the prominent Sp-family transcription factors in neurons.","date":"2007","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17316402","citation_count":44,"is_preprint":false},{"pmid":"11259630","id":"PMC_11259630","title":"Regulation of human monoamine oxidase B gene by Sp1 and Sp3.","date":"2001","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11259630","citation_count":42,"is_preprint":false},{"pmid":"17923686","id":"PMC_17923686","title":"Transcription factor Sp3 knockout mice display serious cardiac malformations.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17923686","citation_count":41,"is_preprint":false},{"pmid":"15118068","id":"PMC_15118068","title":"Regulation of the human secretin gene is controlled by the combined effects of CpG methylation, Sp1/Sp3 ratio, and the E-box element.","date":"2004","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15118068","citation_count":40,"is_preprint":false},{"pmid":"12676787","id":"PMC_12676787","title":"Impaired hematopoiesis in mice lacking the transcription factor Sp3.","date":"2003","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12676787","citation_count":39,"is_preprint":false},{"pmid":"14766015","id":"PMC_14766015","title":"Concentration-dependent effects of endogenous S-nitrosoglutathione on gene regulation by specificity proteins Sp3 and Sp1.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/14766015","citation_count":39,"is_preprint":false},{"pmid":"11054558","id":"PMC_11054558","title":"Sp1 and Sp3 transactivate the RET proto-oncogene promoter.","date":"2000","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/11054558","citation_count":38,"is_preprint":false},{"pmid":"12939287","id":"PMC_12939287","title":"Regulation of the integrin subunit alpha5 gene promoter by the transcription factors Sp1/Sp3 is influenced by the cell density in rabbit corneal epithelial cells.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12939287","citation_count":38,"is_preprint":false},{"pmid":"12657578","id":"PMC_12657578","title":"Influence of sp1/sp3 expression on corneal epithelial cells proliferation and differentiation properties in reconstructed tissues.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12657578","citation_count":37,"is_preprint":false},{"pmid":"16492704","id":"PMC_16492704","title":"Sp1 and Sp3 foci distribution throughout mitosis.","date":"2006","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/16492704","citation_count":36,"is_preprint":false},{"pmid":"20442780","id":"PMC_20442780","title":"Differential control of Notch1 gene transcription by Klf4 and Sp3 transcription factors in normal versus cancer-derived keratinocytes.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20442780","citation_count":36,"is_preprint":false},{"pmid":"15550398","id":"PMC_15550398","title":"Dystrophin Dp71 expression is down-regulated during myogenesis: role of Sp1 and Sp3 on the Dp71 promoter activity.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15550398","citation_count":36,"is_preprint":false},{"pmid":"14613864","id":"PMC_14613864","title":"Sp1 and Sp3 transcription factors are required for trans-activation of the human SERCA2 promoter in cardiomyocytes.","date":"2003","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/14613864","citation_count":36,"is_preprint":false},{"pmid":"23558680","id":"PMC_23558680","title":"Interactions between NF-κB and SP3 connect inflammatory signaling with reduced FGF-10 expression.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23558680","citation_count":35,"is_preprint":false},{"pmid":"15831526","id":"PMC_15831526","title":"Regulation of cytochrome b5 gene transcription by Sp3, GATA-6, and steroidogenic factor 1 in human adrenal NCI-H295A cells.","date":"2005","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15831526","citation_count":35,"is_preprint":false},{"pmid":"17241874","id":"PMC_17241874","title":"Butyrate induces intestinal sodium absorption via Sp3-mediated transcriptional up-regulation of epithelial sodium channels.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17241874","citation_count":35,"is_preprint":false},{"pmid":"36759621","id":"PMC_36759621","title":"Angiotensin-converting enzyme inhibitor promotes angiogenesis through Sp1/Sp3-mediated inhibition of notch signaling in male mice.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36759621","citation_count":34,"is_preprint":false},{"pmid":"12584202","id":"PMC_12584202","title":"Oncogenic Ha-Ras transformation modulates the transcription of the CTP:phosphocholine cytidylyltransferase alpha gene via p42/44MAPK and transcription factor Sp3.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12584202","citation_count":33,"is_preprint":false},{"pmid":"35219905","id":"PMC_35219905","title":"SP3-Enabled Rapid and High Coverage Chemoproteomic Identification of Cell-State-Dependent Redox-Sensitive Cysteines.","date":"2022","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/35219905","citation_count":32,"is_preprint":false},{"pmid":"15849196","id":"PMC_15849196","title":"SP3/SP1 transcription activity regulates specific expression of collagen type X in hypertrophic chondrocytes.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15849196","citation_count":32,"is_preprint":false},{"pmid":"16456404","id":"PMC_16456404","title":"Sodium butyrate-mediated Sp3 acetylation represses human insulin-like growth factor binding protein-3 expression in intestinal epithelial cells.","date":"2006","source":"Journal of pediatric gastroenterology and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/16456404","citation_count":32,"is_preprint":false},{"pmid":"16671893","id":"PMC_16671893","title":"NF-Y and Sp1/Sp3 are involved in the transcriptional regulation of the peptidylarginine deiminase type III gene (PADI3) in human keratinocytes.","date":"2006","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/16671893","citation_count":32,"is_preprint":false},{"pmid":"11114162","id":"PMC_11114162","title":"spr-2, a suppressor of the egg-laying defect caused by loss of sel-12 presenilin in Caenorhabditis elegans, is a member of the SET protein subfamily.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11114162","citation_count":32,"is_preprint":false},{"pmid":"19212434","id":"PMC_19212434","title":"Dual role of Sp3 transcription factor as an inducer of apoptosis and a marker of tumour aggressiveness.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19212434","citation_count":32,"is_preprint":false},{"pmid":"18031229","id":"PMC_18031229","title":"Regulation of the dual-function transcription factor Sp3 by SUMO.","date":"2007","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/18031229","citation_count":31,"is_preprint":false},{"pmid":"18314536","id":"PMC_18314536","title":"Transcription factors sp1 and sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts.","date":"2008","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18314536","citation_count":31,"is_preprint":false},{"pmid":"11742542","id":"PMC_11742542","title":"Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11742542","citation_count":31,"is_preprint":false},{"pmid":"23028678","id":"PMC_23028678","title":"Predictive value of Sp1/Sp3/FLIP signature for prostate cancer recurrence.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23028678","citation_count":30,"is_preprint":false},{"pmid":"12591615","id":"PMC_12591615","title":"Regulation of renin enhancer activity by nuclear factor I and Sp1/Sp3.","date":"2003","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12591615","citation_count":30,"is_preprint":false},{"pmid":"17540780","id":"PMC_17540780","title":"Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-gamma/TNF-alpha.","date":"2007","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17540780","citation_count":30,"is_preprint":false},{"pmid":"8776721","id":"PMC_8776721","title":"Distal Sp3 binding sites in the hIGBP-1 gene promoter suppress transcriptional repression in decidualized human endometrial stromal cells: identification of a novel Sp3 form in decidual cells.","date":"1996","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/8776721","citation_count":30,"is_preprint":false},{"pmid":"15494207","id":"PMC_15494207","title":"Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.","date":"2005","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/15494207","citation_count":29,"is_preprint":false},{"pmid":"15451063","id":"PMC_15451063","title":"Sp3 repression of polymorphic human NRH:quinone oxidoreductase 2 gene promoter.","date":"2004","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15451063","citation_count":28,"is_preprint":false},{"pmid":"17517765","id":"PMC_17517765","title":"Sp1 and Sp3 regulate basal transcription of the human APOBEC3G gene.","date":"2007","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/17517765","citation_count":28,"is_preprint":false},{"pmid":"16275928","id":"PMC_16275928","title":"Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3.","date":"2005","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16275928","citation_count":28,"is_preprint":false},{"pmid":"10512200","id":"PMC_10512200","title":"Binding of Sp1 and Sp3 transcription factors to the Oct-4 gene promoter.","date":"1999","source":"Cellular and molecular biology (Noisy-le-Grand, France)","url":"https://pubmed.ncbi.nlm.nih.gov/10512200","citation_count":27,"is_preprint":false},{"pmid":"12911579","id":"PMC_12911579","title":"Functional characterization of transcription factor binding sites for HNF1-alpha, HNF3-beta (FOXA2), HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer.","date":"2003","source":"Journal of thrombosis and haemostasis : JTH","url":"https://pubmed.ncbi.nlm.nih.gov/12911579","citation_count":27,"is_preprint":false},{"pmid":"17059557","id":"PMC_17059557","title":"Regulation of neurotrophin-3 gene transcription by Sp3 and Sp4 in neurons.","date":"2006","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17059557","citation_count":26,"is_preprint":false},{"pmid":"20519498","id":"PMC_20519498","title":"Transcription of the transforming growth factor beta activating integrin beta8 subunit is regulated by SP3, AP-1, and the p38 pathway.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20519498","citation_count":26,"is_preprint":false},{"pmid":"9610763","id":"PMC_9610763","title":"Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter.","date":"1998","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/9610763","citation_count":26,"is_preprint":false},{"pmid":"31164147","id":"PMC_31164147","title":"Robust hematopoietic specification requires the ubiquitous Sp1 and Sp3 transcription factors.","date":"2019","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/31164147","citation_count":25,"is_preprint":false},{"pmid":"32721022","id":"PMC_32721022","title":"ZEB1 Mediates Fibrosis in Corneal Endothelial Mesenchymal Transition Through SP1 and SP3.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32721022","citation_count":25,"is_preprint":false},{"pmid":"10198359","id":"PMC_10198359","title":"Perinatal regulation of the ClC-2 chloride channel in lung is mediated by Sp1 and Sp3.","date":"1999","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10198359","citation_count":24,"is_preprint":false},{"pmid":"17150965","id":"PMC_17150965","title":"Hydroxyurea and interleukin-6 synergistically reactivate HIV-1 replication in a latently infected promonocytic cell line via SP1/SP3 transcription factors.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17150965","citation_count":24,"is_preprint":false},{"pmid":"11114295","id":"PMC_11114295","title":"MRG1 expression in fibroblasts is regulated by Sp1/Sp3 and an Ets transcription factor.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11114295","citation_count":23,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":49906,"output_tokens":6838,"usd":0.126144},"stage2":{"model":"claude-opus-4-6","input_tokens":10528,"output_tokens":3341,"usd":0.204247},"total_usd":0.330391,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Sp3 represses Sp1-mediated transcriptional activation by competing with Sp1 for shared GC-box binding sites; a DNA-binding domain deletion mutant of Sp3 fails to inhibit Sp1, confirming competition-based mechanism. Sp3 cannot activate transcription in Drosophila SL2 cells lacking endogenous Sp factors, and chimeric domain-swap experiments show that Sp3 glutamine-rich and D domains cannot functionally replace Sp1 counterparts.\",\n      \"method\": \"Co-transfection in mammalian cells and Drosophila SL2 cells, deletion/chimeric mutant analysis, antibody generation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods (loss-of-function mutants, chimeric proteins, heterologous cell system), foundational study replicated across labs\",\n      \"pmids\": [\"8070411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The Sp3 gene encodes multiple protein isoforms via internal translational initiation within the trans-activation domain; internally initiated Sp3 proteins (80 kDa) bind GC boxes but lack transcriptional activation capacity and instead function as potent repressors of Sp1/Sp3-mediated transcription.\",\n      \"method\": \"In vitro translation, transfection of reporter constructs, immunoblotting, mutational mapping of internal start sites\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (in vitro translation, functional reporter assays, mutational analysis) in single study\",\n      \"pmids\": [\"9224612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Sp3 is sumoylated at a single lysine residue (K551) in vivo and in vitro; SUMO modification represses Sp3 transcriptional activity and relocalizes it to the nuclear periphery and nuclear dots. The SUMO-1 protease SuPr-1 or mutation of acceptor lysines converts Sp3 to a strong activator with diffuse nuclear localization. Covalent SUMO-1 fusion to Sp3 is sufficient to recapitulate repression and relocalization.\",\n      \"method\": \"SUMO acceptor lysine mutagenesis, SUMO-1 protease expression, SUMO-1 gene fusion, indirect immunofluorescence, transcription reporter assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution (gene fusion), mutagenesis, localization imaging, and functional assays in one study\",\n      \"pmids\": [\"12419227\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"PIAS1 acts as an E3 SUMO ligase for Sp3, stimulating SUMO conjugation at lysine within the IKXE motif located between the second glutamine-rich activation domain and the DNA-binding domain. SUMO-modified Sp3 binds DNA with similar specificity/affinity as unmodified Sp3, but DNA-bound Sp3 does not serve as a substrate for SUMO modification.\",\n      \"method\": \"In vivo and in vitro SUMO conjugation assays, mutational analysis of IKXE motif, co-immunoprecipitation of PIAS1 with Sp3 and Ubc9, transcriptional reporter assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro and in vivo assays with mutagenesis, identification of E3 ligase, replicated concept from PMID 12419227\",\n      \"pmids\": [\"12356736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sp3 transcriptional activity is regulated by acetylation; a single lysine residue is responsible for low in vivo activity of Sp3. Sp3 is highly acetylated in vivo, whereas a lysine mutant is not. In an in vitro transcription assay with Sp1/Sp3-depleted HeLa nuclear extract, recombinant Sp3 acts as a strong activator similar to Sp1, indicating that in vivo repression is post-translational.\",\n      \"method\": \"In vitro transcription assay with depleted nuclear extract, site-directed mutagenesis, in vivo acetylation assay, stable insect cell expression of recombinant proteins\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution combined with mutagenesis and in vivo acetylation measurement\",\n      \"pmids\": [\"11812829\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Genetic knockout of mouse Sp3 results in growth retardation, perinatal death due to respiratory failure, and pronounced defect in late tooth formation with impaired ameloblast-specific gene expression; Sp3-null phenotype is distinct from Sp1 knockout, demonstrating non-redundant in vivo functions.\",\n      \"method\": \"Homologous recombination gene knockout in mice, histology, surfactant protein expression analysis, comparison with Sp1 knockout phenotype\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined multi-organ phenotypic readouts, foundational in vivo study\",\n      \"pmids\": [\"10675334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"SUMO-modified Sp3 bound to DNA provokes local heterochromatic gene silencing by recruiting chromatin remodeller Mi-2, MBT-domain proteins, HP1, and histone methyltransferases SETDB1 and SUV4-20H, leading to H3K9 and H4K20 trimethylation.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), reporter assays, sumoylation-competent/deficient Sp3 constructs\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with multiple histone marks and co-repressor recruitment, mechanistically detailed\",\n      \"pmids\": [\"18617891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Sp3 forms a separate complex from Sp1 in breast cancer cells and associates with CK2-phosphorylated HDAC2; protein kinase CK2 is associated with and phosphorylates HDAC2 recruited by Sp3, and alkaline phosphatase treatment reduces HDAC activity in Sp3 complexes.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assay, alkaline phosphatase treatment, chromatin crosslinking\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, in vitro kinase assay, and enzymatic validation\",\n      \"pmids\": [\"12176973\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Sp3 facilitates recruitment of HDAC2 to synaptic plasticity gene promoters in neurons; Sp3 knockdown phenocopies HDAC2 knockdown in reducing synaptic gene expression, and an HDAC2 fragment containing the Sp3-binding domain restores synaptic plasticity in a neurodegeneration mouse model.\",\n      \"method\": \"RNAi knockdown, integrative genomics/ChIP-seq, exogenous HDAC2 fragment rescue in mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional genomics, KD phenocopy, in vivo rescue experiment with defined molecular domain\",\n      \"pmids\": [\"28793257\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Sp3 is expressed as four isoforms arising from alternative translational start sites at positions 1, 37, 856, and 907; none of the isoforms is glycosylated (unlike Sp1); all four isoforms are SUMO-modified exclusively at lysine 551 in vivo and in vitro; the two long isoforms show promoter-context-dependent transcriptional activity regulated by SUMO modification, while the small isoforms are transcriptionally inactive.\",\n      \"method\": \"Immunoblot analysis in Sp3-deficient cell lines, in vitro SUMO conjugation, mutagenesis, translational initiation mapping, transcriptional reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Sp3-null cell validation, in vitro SUMO assay, mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"15247228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Sp3 binds promoters containing multiple adjacent Sp-binding sites as a more stable multimeric complex compared to monomeric binding at single sites, and this promoter-dependent binding stability enables Sp3 to efficiently compete with Sp1 at multi-site promoters, blocking Sp1 synergistic transactivation without Sp3 itself synergistically activating transcription.\",\n      \"method\": \"EMSA mobility shift analysis, promoter-specific transcription assays, complex stability measurements\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic EMSA and functional assays but single lab, single study\",\n      \"pmids\": [\"12954773\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sp3 is required for proper skeletal ossification; both endochondral and intramembranous ossification are impaired in Sp3-/- embryos, osteocalcin expression is reduced, and Sp3-/- ES cells show reduced osteogenic differentiation capacity in vitro despite normal Cbfa1 expression.\",\n      \"method\": \"Sp3 knockout mice analysis, in vitro ES cell osteogenic differentiation, gene expression analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and molecular phenotype, in vitro differentiation assay corroboration\",\n      \"pmids\": [\"11472836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Sp3 is required for normal hematopoiesis; Sp3-/- mice show T-cell developmental arrest, reduced B-cell numbers, and a cell-autonomous defect in erythroid and myeloid engraftment in transplantation assays, with a specific delay in definitive erythropoiesis.\",\n      \"method\": \"Sp3 knockout mice analysis, in vitro differentiation, in vivo bone marrow transplantation assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with cell-autonomous proof via transplantation, defined lineage-specific phenotypes\",\n      \"pmids\": [\"12676787\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Sp3-null mice on C57BL/6 background develop severe cardiac malformations including defective heart looping at E10.5 and structural defects by E14.5; ChIP shows Sp3 directly bound to the Carp promoter in vivo, and Carp expression is prematurely downregulated in Sp3-null hearts; Wt1 expression in epicardium-derived cells is also diminished.\",\n      \"method\": \"Sp3 knockout mice cardiac analysis, ChIP assay for Carp promoter occupancy, microarray analysis, marker gene expression panel\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined phenotype, ChIP validation of direct target binding, microarray pathway analysis\",\n      \"pmids\": [\"17923686\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Combined conditional knockout of Sp1 and Sp3 in megakaryocytes causes severe macrothrombocytopenia with a cell-autonomous defect in proplatelet formation and a less compact demarcation membrane system; Sp1/Sp3 depletion downregulates cytoskeleton-related proteins including Mylk, and Mylk inhibition phenocopies the proplatelet defect.\",\n      \"method\": \"Pf4-Cre conditional double-knockout mice, flow cytometry, electron microscopy, megakaryocyte transcriptomics, platelet proteomics, Mylk inhibitor treatment\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific conditional KO with multi-omic validation and pharmacological phenocopy\",\n      \"pmids\": [\"25538045\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"c-Myc interacts with Sp1/Sp3 via the central region of c-Myc binding to the zinc finger domain of Sp1/Sp3, and this interaction likely sequesters Sp1/Sp3 to repress p21 promoter activity; the p21 promoter region repressed by Myc contains only Sp1-binding sites and no canonical Myc E-box.\",\n      \"method\": \"Co-immunoprecipitation, GST pulldown, transcriptional reporter assays, 4-OHT-inducible Myc-ER fusion\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP and GST pulldown demonstrate physical interaction; functional link established by reporter assay\",\n      \"pmids\": [\"11274368\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Glutamate receptor activation triggers calpain-mediated cleavage of Sp3 and Sp4 in neurons; purified calpain I cleaves Sp3 into products that retain GC/T-binding activity; this is blocked by calpain inhibitors and observed after cerebral ischemia/reperfusion in vivo.\",\n      \"method\": \"In vitro calpain cleavage assay with purified proteins, calpain inhibitor treatment, in vivo ischemia model, immunofluorescence, western blot\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — purified protein in vitro cleavage assay corroborated by inhibitor studies and in vivo model\",\n      \"pmids\": [\"17316402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Sp3 interacts with GABPα through its zinc finger DNA-binding domain, and both Sp1 and Sp3 synergistically activate the utrophin promoter together with GABP; physical interaction between Sp factors and GABPα was demonstrated by in vitro binding assays and domain mapping.\",\n      \"method\": \"In vitro protein-protein interaction assays, domain deletion analysis, co-transfection in Drosophila SL2 cells, transcriptional reporter assays\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro pulldown with domain mapping; functional synergy demonstrated in heterologous cells\",\n      \"pmids\": [\"11237613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p300 physically interacts with Sp3 in vivo and in vitro, and cotransfection of p300 elevates Sp3-mediated activation of the p21 promoter; a p300 dominant-negative mutant blocks Sp1- or Sp3-mediated activation, placing p300 as a co-activator of Sp3.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, dominant-negative p300 co-transfection, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and in vitro binding plus dominant-negative functional validation; single lab\",\n      \"pmids\": [\"12071960\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Sp1 and Sp3 are organized into distinct non-overlapping nuclear domains in human cells; Sp3 partitions preferentially with the tightly bound nuclear protein fraction and nuclear matrix, while Sp1 and Sp3 associate with different nuclear matrix attachment sites; ChIP/re-ChIP shows Sp1 and Sp3 do not co-occupy the same trefoil factor 1 promoter simultaneously.\",\n      \"method\": \"Indirect immunofluorescence with deconvolution microscopy, nuclear fractionation, nuclear matrix preparation, ChIP and re-ChIP assays\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal localization methods and re-ChIP demonstrating mutually exclusive promoter occupancy\",\n      \"pmids\": [\"15987735\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Sumoylation of internally initiated Sp3 isoforms (M1 and M2) is required for their repressive activity; mutation of K551 converts M1 from a repressor into a potent transcriptional activator; Ubc9 (SUMO-1 conjugating enzyme) was identified as an M2-binding protein by yeast two-hybrid.\",\n      \"method\": \"Yeast two-hybrid screen, in vivo SUMO conjugation assay, K551R mutagenesis, transcriptional reporter assays\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis and SUMO assays; yeast two-hybrid interaction supported by functional data\",\n      \"pmids\": [\"15494207\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sp3 acetylation (catalyzed by p300 acetyltransferase) in response to sodium butyrate represses hIGFBP-3 expression; EMSA of nuclei from butyrate-treated cells reveals an extra, slower Sp3-DNA complex recognized by both anti-Sp3 and anti-acetyl-lysine antibodies; E1A (p300 inhibitor) reverses butyrate-induced repression.\",\n      \"method\": \"EMSA with antibody detection, E1A co-transfection, reporter assays, inhibitor treatment\",\n      \"journal\": \"Journal of pediatric gastroenterology and nutrition\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — dual-antibody EMSA and functional rescue; single lab, limited direct acetyltransferase assay\",\n      \"pmids\": [\"16456404\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"NF-κB RELA subunit interacts with SP3 and this RELA-SP3 interaction is enhanced by NF-κB activation (LPS or constitutively active IKKβ); the RELA-SP3 complex suppresses SP1-mediated FGF-10 transcription; the N-terminal region of SP3 is required for its inhibitory function; dominant-negative IκB prevents SP3-mediated FGF-10 inhibition.\",\n      \"method\": \"ChIP of Fgf-10 promoter in LPS-treated cells, co-IP of RELA and SP3, constitutively active/dominant-negative IKK constructs, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and Co-IP with mechanistic functional validation; single lab\",\n      \"pmids\": [\"23558680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sp3 binds the Notch1 gene promoter and represses its transcription in keratinocytes; combined Klf4 and Sp3 knockdown is required to increase Notch1 transcription, indicating overlapping repressor functions through promoter binding.\",\n      \"method\": \"Combined siRNA knockdown, reporter assays with GC-rich promoter, binding analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional knockdown data, promoter binding shown; no direct ChIP or in vitro reconstitution\",\n      \"pmids\": [\"20442780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Sp3 mRNA is predominant in neurons (compared to Sp1), and Sp3 protein is present at lower levels in glia; calpain cleaves Sp3 into species that retain DNA binding activity, with cleavage also occurring after ischemia/reperfusion in vivo.\",\n      \"method\": \"RT-PCR, western blot, immunofluorescence, DNA-binding supershift assay, purified calpain in vitro cleavage\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro cleavage with purified enzyme plus in vivo validation; same paper as PMID 17316402\",\n      \"pmids\": [\"17316402\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"In cortical neurons, Sp3 (along with Sp3/Sp4) is the predominant Sp-family DNA-binding factor rather than Sp1; full-length Sp3 overexpression prevents neuronal death in response to oxidative stress and DNA damage in a DNA-binding-domain-dependent manner.\",\n      \"method\": \"Overexpression of full-length Sp3 vs. zinc-finger-only constructs, neuronal survival assay under oxidative stress, western blot/nuclear fractionation\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-specific rescue and defined cell death assay; single study\",\n      \"pmids\": [\"12736330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ChIP-seq in mouse embryonic fibroblasts shows Sp1 and Sp3 occupy essentially the same promoters and localize to GC boxes genome-wide; re-expression of Sp3 in knockout MEFs confirms that the zinc finger domain dictates Sp3 genomic binding site selection, distinguishing it from Sp2.\",\n      \"method\": \"ChIP-seq, re-expression in knockout MEFs, zinc-finger deletion mutants\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — genome-wide ChIP-seq with mutant rescue in KO cells\",\n      \"pmids\": [\"25793500\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Sp3, together with ATF-2, forms a complex at the ITGB8 (integrin β8) core promoter in a p38 MAPK-dependent manner; Sp3 is required for ITGB8 transcription and protein expression, and SP3 reduction blocks αvβ8-mediated TGF-β activation.\",\n      \"method\": \"ChIP, co-IP showing Sp1/Sp3/AP-1 complex, siRNA knockdown, p38 inhibitor, reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and co-IP with functional pathway validation; single lab\",\n      \"pmids\": [\"20519498\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Sp3 and Sp1 binding sites largely overlap in hematopoietic progenitors by ChIP-seq; Sp3 cooperates with a DNA-binding mutant of Sp1 (Sp1ΔDBD) to enable hematopoiesis, but cannot rescue hematopoiesis in complete absence of Sp1; Sp1 DNA binding is required for proper timing and coordination of differentiation trajectories as revealed by single-cell gene expression analysis.\",\n      \"method\": \"ChIP-seq, genetic complementation in Sp1ΔDBD ES cells, single-cell gene expression analysis, in vitro hematopoietic differentiation\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide ChIP-seq, genetic complementation, single-cell analysis; multiple orthogonal approaches\",\n      \"pmids\": [\"31164147\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SP3 is a ubiquitous GC-box-binding zinc-finger transcription factor that can both activate and repress transcription depending on promoter context, post-translational modification state, and isoform: it competes with Sp1 for shared binding sites, is sumoylated at K551 by the E3 ligase PIAS1 (leading to transcriptional silencing via heterochromatin formation involving SETDB1, SUV4-20H, and HP1 recruitment), is regulated by acetylation and calpain-mediated cleavage, forms distinct nuclear complexes with HDAC2 (recruited to synaptic genes) and interacts physically with p300, RELA/NF-κB, and GABP; Sp3 is essential in vivo for tooth development, ossification, hematopoiesis, cardiac morphogenesis, and platelet formation, as demonstrated by knockout mouse studies.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SP3 is a ubiquitously expressed zinc-finger transcription factor that binds GC-box elements genome-wide, functioning as both an activator and a repressor of transcription depending on isoform, promoter context, and post-translational modification state. SP3 competes with SP1 for shared GC-box sites, and its shorter internally initiated isoforms lack activation capacity, serving as potent transcriptional repressors [PMID:8070411, PMID:9224612, PMID:25793500]. SUMO conjugation at K551, mediated by the E3 ligase PIAS1, converts SP3 into a silencer that recruits heterochromatin factors including SETDB1, SUV4-20H, HP1, and Mi-2, leading to H3K9 and H4K20 trimethylation, while acetylation by p300 and calpain-mediated cleavage provide additional regulatory inputs [PMID:12419227, PMID:12356736, PMID:18617891, PMID:17316402]. SP3 is essential in vivo for tooth development, ossification, hematopoiesis, cardiac morphogenesis, and proplatelet formation, demonstrating non-redundant functions distinct from SP1 [PMID:10675334, PMID:11472836, PMID:12676787, PMID:17923686, PMID:25538045].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing that SP3 is not simply redundant with SP1 but acts as a GC-box competitor that represses SP1-mediated activation, answering the fundamental question of why two factors with identical DNA-binding specificity coexist.\",\n      \"evidence\": \"Co-transfection in mammalian and Drosophila SL2 cells with deletion and chimeric mutants of SP3\",\n      \"pmids\": [\"8070411\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of repression beyond site competition was unknown\", \"Whether SP3 could activate transcription in any context remained open\", \"In vivo relevance of competition not tested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Discovery that the SP3 gene produces multiple isoforms via internal translational initiation resolved why SP3 behaves as a repressor in most contexts — the shorter isoforms lack activation domains and act as dominant repressors.\",\n      \"evidence\": \"In vitro translation, mutagenesis of internal start sites, reporter assays\",\n      \"pmids\": [\"9224612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Post-translational modifications of individual isoforms not characterized\", \"Relative abundance of isoforms in different tissues unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Knockout of SP3 in mice revealed essential, non-redundant in vivo roles in tooth development and surfactant production, establishing that SP3 loss is not compensated by SP1.\",\n      \"evidence\": \"Homologous recombination gene knockout in mice with histological and gene expression analysis\",\n      \"pmids\": [\"10675334\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets in ameloblasts not identified\", \"Cause of respiratory failure not fully dissected\", \"Conditional tissue-specific requirements not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Two parallel discoveries — that SP3 is regulated by acetylation at a critical lysine and that SP3 is required for skeletal ossification — expanded the picture of SP3 as a post-translationally regulated factor with broad developmental functions.\",\n      \"evidence\": \"In vitro transcription with SP1/SP3-depleted nuclear extract and acetylation mutagenesis (PMID:11812829); SP3 knockout mouse skeletal analysis and ES cell osteogenic differentiation (PMID:11472836)\",\n      \"pmids\": [\"11812829\", \"11472836\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the acetyltransferase responsible in vivo not determined at this stage\", \"Relationship between acetylation and sumoylation at the same or nearby lysines unclear\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"The discovery that SUMO modification at K551, catalyzed by E3 ligase PIAS1, switches SP3 from activator to repressor and relocalizes it to nuclear bodies provided the central post-translational mechanism controlling SP3 activity.\",\n      \"evidence\": \"SUMO acceptor lysine mutagenesis, SUMO-1 gene fusions, immunofluorescence, in vitro/in vivo SUMO conjugation assays with PIAS1\",\n      \"pmids\": [\"12419227\", \"12356736\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SUMO-SP3 recruits silencing machinery not yet established\", \"Regulation of PIAS1-mediated sumoylation in physiological contexts unknown\", \"Whether desumoylation is signal-regulated not addressed\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Identification of SP3 in a distinct nuclear complex with CK2-phosphorylated HDAC2, separate from SP1 complexes, established that SP3 mediates transcriptional repression through histone deacetylase recruitment.\",\n      \"evidence\": \"Reciprocal co-immunoprecipitation, in vitro kinase assay, alkaline phosphatase treatment in breast cancer cells\",\n      \"pmids\": [\"12176973\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genomic targets of the SP3-HDAC2 complex not mapped\", \"Whether SUMO modification of SP3 is required for HDAC2 interaction not tested\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Demonstration of cell-autonomous hematopoietic defects in SP3-null mice — including arrested T-cell development, reduced B cells, and impaired erythropoiesis — broadened SP3's essential developmental roles to the blood system.\",\n      \"evidence\": \"SP3 knockout mice with bone marrow transplantation proving cell-autonomous defects, in vitro differentiation assays\",\n      \"pmids\": [\"12676787\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets in hematopoietic progenitors not identified\", \"Relative contribution of SP3 isoforms to hematopoiesis unknown\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"High-resolution imaging and re-ChIP studies revealed that SP1 and SP3 occupy distinct non-overlapping nuclear domains and do not co-occupy the same promoter molecule simultaneously, reframing the competition model as one of mutually exclusive occupancy.\",\n      \"evidence\": \"Deconvolution microscopy, nuclear matrix fractionation, ChIP/re-ChIP at trefoil factor 1 promoter\",\n      \"pmids\": [\"15987735\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mutual exclusivity applies genome-wide or only at select loci not determined\", \"Dynamic exchange rates between SP1 and SP3 at promoters not measured\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"SP3 was shown to be essential for cardiac morphogenesis, with direct ChIP evidence of SP3 binding to the Carp promoter in vivo, linking SP3 loss to defective heart looping and structural malformations.\",\n      \"evidence\": \"SP3 knockout mice on C57BL/6 background, ChIP of Carp promoter, microarray analysis of E10.5 hearts\",\n      \"pmids\": [\"17923686\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full set of direct cardiac target genes not delineated\", \"Whether cardiac defect is SP3-isoform specific not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The mechanistic link between SUMO-SP3 and heterochromatin was completed by showing that DNA-bound sumoylated SP3 recruits Mi-2, MBT-domain proteins, HP1, SETDB1, and SUV4-20H to trigger H3K9me3 and H4K20me3, explaining how a single transcription factor nucleates stable gene silencing.\",\n      \"evidence\": \"ChIP for multiple histone marks and co-repressor proteins using sumoylation-competent and -deficient SP3 constructs\",\n      \"pmids\": [\"18617891\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether this heterochromatin mechanism operates at endogenous SP3 target genes genome-wide unknown\", \"Structural basis for SUMO-dependent co-repressor recruitment not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Genome-wide ChIP-seq confirmed that SP1 and SP3 occupy essentially identical GC-box promoter sites, and that the zinc-finger domain alone dictates SP3 binding-site selection, resolving the question of genomic target overlap at a global scale.\",\n      \"evidence\": \"ChIP-seq in wild-type and SP3 knockout MEFs with zinc-finger deletion mutant re-expression\",\n      \"pmids\": [\"25793500\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"What determines differential functional outcomes (activation vs. repression) at shared sites not explained by binding alone\", \"Contribution of non-DNA-binding cofactor interactions to target gene selectivity unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"SP3 was shown to facilitate HDAC2 recruitment specifically to synaptic plasticity gene promoters in neurons, with SP3 knockdown phenocopying HDAC2 loss, establishing a neuronal gene-regulatory function for the SP3-HDAC2 axis.\",\n      \"evidence\": \"RNAi knockdown, ChIP-seq, and HDAC2 fragment rescue in a neurodegeneration mouse model\",\n      \"pmids\": [\"28793257\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SP3 sumoylation is required for HDAC2 recruitment to synaptic genes not tested\", \"Which SP3 isoforms operate in mature neurons not determined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Single-cell and ChIP-seq analyses in hematopoietic progenitors showed that SP3 cooperates with SP1 but cannot substitute for SP1's DNA-binding function, establishing a model of obligate SP1-SP3 partnership rather than simple redundancy in hematopoiesis.\",\n      \"evidence\": \"ChIP-seq in hematopoietic progenitors, genetic complementation with SP1 DNA-binding-domain mutant, single-cell gene expression profiling\",\n      \"pmids\": [\"31164147\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical nature of SP1-SP3 functional cooperation at shared sites not defined\", \"Whether SP3-specific cofactors contribute to non-redundant hematopoietic functions unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how cells regulate the switch between activating and repressive SP3 states at specific genomic loci, including the signaling pathways that control the balance of SP3 sumoylation, acetylation, and isoform expression in different developmental and physiological contexts.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of SP3 or its SUMO-modified form exists\", \"Genome-wide mapping of SUMO-SP3 versus unmodified SP3 occupancy has not been performed\", \"The interplay between SP3 acetylation and sumoylation at the same critical lysine region is not resolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 10, 26]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 1, 2, 6, 8, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 19]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 6, 8, 26]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 11, 12, 13, 14]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [12, 28]}\n    ],\n    \"complexes\": [\n      \"SP3-HDAC2-CK2 complex\",\n      \"SUMO-SP3/SETDB1/HP1/Mi-2 silencing complex\"\n    ],\n    \"partners\": [\n      \"SP1\",\n      \"HDAC2\",\n      \"PIAS1\",\n      \"UBE2I\",\n      \"EP300\",\n      \"RELA\",\n      \"GABPA\",\n      \"MYC\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}